<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37313407</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Cuproptosis-related gene identification and immune infiltration analysis in systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>1157196</StartPage><MedlinePgn>1157196</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1157196</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1157196</ELocationID><Abstract><AbstractText Label="BACKGROUND">Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by loss of tolerance to self-antigen, autoantibody production, and abnormal immune response. Cuproptosis is a recently reported cell death form correlated with the initiation and development of multiple diseases. This study intended to probe cuproptosis-related molecular clusters in SLE and constructed a predictive model.</AbstractText><AbstractText Label="METHODS">We analyzed the expression profile and immune features of cuproptosis-related genes (CRGs) in SLE based on GSE61635 and GSE50772 datasets and identified core module genes associated with SLE occurrence using the weighted correlation network analysis (WGCNA). We selected the optimal machine-learning model by comparing the random forest (RF) model, support vector machine (SVM) model, generalized linear model (GLM), and the extreme gradient boosting (XGB) model. The predictive performance of the model was validated by nomogram, calibration curve, decision curve analysis (DCA), and external dataset GSE72326. Subsequently, a CeRNA network based on 5 core diagnostic markers was established. Drugs targeting core diagnostic markers were acquired using the CTD database, and Autodock vina software was employed to perform molecular docking.</AbstractText><AbstractText Label="RESULTS">Blue module genes identified using WGCNA were highly related to SLE initiation. Among the four machine-learning models, the SVM model presented the best discriminative performance with relatively low residual and root-mean-square error (RMSE) and high area under the curve (AUC = 0.998). An SVM model was constructed based on 5 genes and performed favorably in the GSE72326 dataset for validation (AUC = 0.943). The nomogram, calibration curve, and DCA validated the predictive accuracy of the model for SLE as well. The CeRNA regulatory network includes 166 nodes (5 core diagnostic markers, 61 miRNAs, and 100 lncRNAs) and 175 lines. Drug detection showed that D00156 (Benzo (a) pyrene), D016604 (Aflatoxin B1), D014212 (Tretinoin), and D009532 (Nickel) could simultaneously act on the 5 core diagnostic markers.</AbstractText><AbstractText Label="CONCLUSION">We revealed the correlation between CRGs and immune cell infiltration in SLE patients. The SVM model using 5 genes was selected as the optimal machine learning model to accurately evaluate SLE patients. A CeRNA network based on 5 core diagnostic markers was constructed. Drugs targeting core diagnostic markers were retrieved with molecular docking performed.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Li, Guan, Wang, Lv, Wu, Yu and Sun.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wuquan</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Binzhou Medical University, Yantai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Xiaoran</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Binzhou Medical University, Yantai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Binzhou Medical University, Yantai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Life Science, Yantai University, Yantai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yuyong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Binzhou Medical University, Yantai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Binzhou Medical University, Yantai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yeying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Binzhou Medical University, Yantai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9N2N2Y55MH</RegistryNumber><NameOfSubstance UI="D016604">Aflatoxin B1</NameOfSubstance></Chemical><Chemical><RegistryNumber>3417WMA06D</RegistryNumber><NameOfSubstance UI="D001564">Benzo(a)pyrene</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>789U1901C5</RegistryNumber><NameOfSubstance UI="D003300">Copper</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016604" MajorTopicYN="N">Aflatoxin B1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001564" MajorTopicYN="N">Benzo(a)pyrene</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003300" MajorTopicYN="N">Copper</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="Y">Apoptosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">WGCNA</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">immune infiltration</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>3</Hour><Minute>57</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37313407</ArticleId><ArticleId IdType="pmc">PMC10258330</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1157196</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tsokos GC, Lo MS, Reis PC, Sullivan KE. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol (2016) 12(12):716&#x2013;30. doi: 10.1038/nrrheum.2016.186</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2016.186</ArticleId><ArticleId IdType="pubmed">27872476</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermansen ML, Lindhardsen J, Torp-Pedersen C, Faurschou M, Jacobsen S. The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study. Rheumatol (Oxford) (2017) 56(5):709&#x2013;15. doi: 10.1093/rheumatology/kew475</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kew475</ArticleId><ArticleId IdType="pubmed">28053276</ArticleId></ArticleIdList></Reference><Reference><Citation>Grammatikos AP, Kyttaris VC, Kis-Toth K, Fitzgerald LM, Devlin A, Finnell MD, et al. . A T cell gene expression panel for the diagnosis and monitoring of disease activity in patients with systemic lupus erythematosus. Clin Immunol (2014) 150(2):192&#x2013;200. doi: 10.1016/j.clim.2013.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2013.12.002</ArticleId><ArticleId IdType="pmc">PMC3932542</ArticleId><ArticleId IdType="pubmed">24434273</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang SC, Hwang SJ, Chang YS, Chou CT, Tsai CY. Characteristics of comorbidities and costs among patients who died from systemic lupus erythematosus in Taiwan. Arch Med Sci (2012) 8(4):690&#x2013;6. doi: 10.5114/aoms.2012.30293</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/aoms.2012.30293</ArticleId><ArticleId IdType="pmc">PMC3460506</ArticleId><ArticleId IdType="pubmed">23056082</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakeland EK, Liu K, Graham RR, Behrens TW. Delineating the genetic basis of systemic lupus erythematosus. Immunity (2001) 15(3):397&#x2013;408. doi: 10.1016/S1074-7613(01)00201-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(01)00201-1</ArticleId><ArticleId IdType="pubmed">11567630</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim BE, Nevitt T, Thiele DJ. Mechanisms for copper acquisition, distribution and regulation. Nat Chem Biol (2008) 4(3):176&#x2013;85. doi: 10.1038/nchembio.72</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.72</ArticleId><ArticleId IdType="pubmed">18277979</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge EJ, Bush AI, Casini A, Cobine PA, Cross JR, DeNicola GM, et al. . Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat Rev Cancer (2022) 22(2):102&#x2013;13. doi: 10.1038/s41568-021-00417-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41568-021-00417-2</ArticleId><ArticleId IdType="pmc">PMC8810673</ArticleId><ArticleId IdType="pubmed">34764459</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutsenko S. Human copper homeostasis: a network of interconnected pathways. Curr Opin Chem Biol (2010) 14(2):211&#x2013;7. doi: 10.1016/j.cbpa.2010.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbpa.2010.01.003</ArticleId><ArticleId IdType="pmc">PMC6365103</ArticleId><ArticleId IdType="pubmed">20117961</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo HR, Wang YQ, Cui HM, Ouyang YJ, Yang TY, Liu CY, et al. . Copper induces spleen damage through modulation of oxidative stress, apoptosis, DNA damage, and inflammation. Biol Trace Elem Res (2022) 200(2):669&#x2013;77. doi: 10.1007/s12011-021-02672-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12011-021-02672-8</ArticleId><ArticleId IdType="pubmed">33740180</ArticleId></ArticleIdList></Reference><Reference><Citation>Jian Z, Guo H, Liu H, Cui H, Fang J, Zuo Z, et al. . Oxidative stress, apoptosis and inflammatory responses involved in copper-induced pulmonary toxicity in mice. Aging (Albany NY) (2020) 12(17):16867&#x2013;86. doi: 10.18632/aging.103585</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103585</ArticleId><ArticleId IdType="pmc">PMC7521514</ArticleId><ArticleId IdType="pubmed">32952128</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. . Copper induces cell death by targeting lipoylated TCA cycle proteins. Science (2022) 375(6586):1254&#x2013;61. doi: 10.1126/science.abf0529</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf0529</ArticleId><ArticleId IdType="pmc">PMC9273333</ArticleId><ArticleId IdType="pubmed">35298263</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P, Jiang M, Li K, Li H, Zhou Y, Xiao X, et al. . Glutathione peroxidase 4-regulated neutrophil ferroptosis induces systemic autoimmunity. Nat Immunol (2021) 22(9):1107&#x2013;17. doi: 10.1038/s41590-021-00993-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00993-3</ArticleId><ArticleId IdType="pmc">PMC8609402</ArticleId><ArticleId IdType="pubmed">34385713</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan HY, Wang N, Zhang C, Chan YT, Yuen MF, Feng Y. Lysyl oxidase-like 4 fosters an immunosuppressive microenvironment during hepatocarcinogenesis. Hepatology (2021) 73(6):2326&#x2013;41. doi: 10.1002/hep.31600</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.31600</ArticleId><ArticleId IdType="pmc">PMC8251926</ArticleId><ArticleId IdType="pubmed">33068461</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodfellow I, Bengio Y, Courville A. Deep learning. MIT press: (2016).</Citation></Reference><Reference><Citation>Oliver A, Odena A, Raffel CA, Cubuk ED, Goodfellow IJ. Realistic evaluation of deep semi-supervised learning algorithms. 32nd Conference on Neural Information Processing Systems (2018). doi:&#xa0;10.48550/arXiv.1804.09170</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1804.09170</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinton GE, Osindero S, Teh YW. A fast learning algorithm for deep belief nets. Neural Comput (2006) 18(7):1527&#x2013;54. doi: 10.1162/neco.2006.18.7.1527</Citation><ArticleIdList><ArticleId IdType="doi">10.1162/neco.2006.18.7.1527</ArticleId><ArticleId IdType="pubmed">16764513</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Guo F, Zhou Z, Zhang F, Wang Q, Peng Z, et al. . [Performance of deep-learning-based artificial intelligence on detection of pulmonary nodules in chest CT]. Zhongguo fei ai za zhi = Chin J Lung Cancer (2019) 22(6):336&#x2013;40. doi:&#xa0;10.3779/j.issn.1009-3419.2019.06.02</Citation><ArticleIdList><ArticleId IdType="doi">10.3779/j.issn.1009-3419.2019.06.02</ArticleId><ArticleId IdType="pmc">PMC6580084</ArticleId><ArticleId IdType="pubmed">31196366</ArticleId></ArticleIdList></Reference><Reference><Citation>Feeny AK, Chung MK, Madabhushi A, Attia ZI, Cikes M, Firouznia M, et al. . Artificial intelligence and machine learning in arrhythmias and cardiac electrophysiology. Circ Arrhythm Electrophysiol (2020) 13(8):e007952. doi: 10.1161/CIRCEP.119.007952</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.119.007952</ArticleId><ArticleId IdType="pmc">PMC7808396</ArticleId><ArticleId IdType="pubmed">32628863</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlegl T, Seeb&#xf6;ck P, Waldstein SM, Schmidt-Erfurth U, Langs G. (2017). Unsupervised anomaly detection with generative adversarial networks to guide marker discovery. Information processing in medical imaging, in: 25th International Conference, IPMI 2017, Boone, NC, USA, June 25-30, 2017. pp. 146&#x2013;57. Proceedings, Springer. doi:&#xa0;10.48550/arXiv.1703.05921</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1703.05921</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi H, Jin KH, Alzheimer&#x2019;s Disease Neuroimaging Initiative . Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging. Behav Brain Res (2018) 344:103&#x2013;9. doi: 10.1016/j.bbr.2018.02.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2018.02.017</ArticleId><ArticleId IdType="pubmed">29454006</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpintero MF, Martinez L, Fernandez I, Romero AC, Mejia C, Zang YJ, et al. . Diagnosis and risk stratification in patients with anti-RNP autoimmunity. Lupus (2015) 24(10):1057&#x2013;66. doi: 10.1177/0961203315575586</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315575586</ArticleId><ArticleId IdType="pmc">PMC4529793</ArticleId><ArticleId IdType="pubmed">25736140</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy WP, Maciuca R, Wolslegel K, Tew W, Abbas AR, Chaivorapol C, et al. . Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE. Lupus Sci Med (2015) 2(1):e000080. doi: 10.1136/lupus-2014-000080</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2014-000080</ArticleId><ArticleId IdType="pmc">PMC4379884</ArticleId><ArticleId IdType="pubmed">25861459</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiche L, Jourde-Chiche N, Whalen E, Presnell S, Gersuk V, Dang K, et al. . Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures. Arthritis Rheumatol (Hoboken N.J.) (2014) 66(6):1583&#x2013;95. doi: 10.1002/art.38628</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.38628</ArticleId><ArticleId IdType="pmc">PMC4157826</ArticleId><ArticleId IdType="pubmed">24644022</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder P, Horvath S. WGCNA: an r package for weighted correlation network analysis. BMC Bioinf (2008) 9:559. doi: 10.1186/1471-2105-9-559</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-9-559</ArticleId><ArticleId IdType="pmc">PMC2631488</ArticleId><ArticleId IdType="pubmed">19114008</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang FZ, Wang B, Long JB, Wang FM, Wu P. Identification of candidate target genes for endometrial cancer, such as ANO1, using weighted gene co-expression network analysis. Exp Ther Med (2019) 17(1):298&#x2013;306. doi:&#xa0;10.3892/etm.2018.6965</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2018.6965</ArticleId><ArticleId IdType="pmc">PMC6307379</ArticleId><ArticleId IdType="pubmed">30651795</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabasi AL. Hierarchical organization of modularity in metabolic networks. Science (2002) 297(5586):1551&#x2013;5. doi: 10.1126/science.1073374</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1073374</ArticleId><ArticleId IdType="pubmed">12202830</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold C, Sollich P. Model selection for support vector machine classification. Neurocomputing (2003) 55(1):221&#x2013;49. doi: 10.1016/S0925-2312(03)00375-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0925-2312(03)00375-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigatti SJ. Random forest. J Insur Med (2017) 47(1):31&#x2013;9. doi: 10.17849/insm-47-01-31-39.1</Citation><ArticleIdList><ArticleId IdType="doi">10.17849/insm-47-01-31-39.1</ArticleId><ArticleId IdType="pubmed">28836909</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelder JA, Wedderburn RWM. Generalized linear models. J R Stat Soc (1972) 135(3):370&#x2013;84. doi: 10.2307/2344614</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2344614</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, He T, Benesty M, Khotilovich V, Tang Y, Cho H, et al. . Xgboost: extreme gradient boosting. The annals of statistics (2015) 1(4):1&#x2013;4.</Citation></Reference><Reference><Citation>Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. . Robust enumeration of cell subsets from tissue expression profiles. Nat Methods (2015) 12(5):453&#x2013;7. doi: 10.1038/nmeth.3337</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3337</ArticleId><ArticleId IdType="pmc">PMC4739640</ArticleId><ArticleId IdType="pubmed">25822800</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakshi J, Segura BT, Wincup C, Rahman A. Unmet needs in the pathogenesis and treatment of systemic lupus erythematosus. Clin Rev Allergy Immunol (2018) 55(3):352&#x2013;67. doi: 10.1007/s12016-017-8640-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-017-8640-5</ArticleId><ArticleId IdType="pmc">PMC6244922</ArticleId><ArticleId IdType="pubmed">28853005</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon C, Amissah-Arthur MB, Gayed M, Brown S, Bruce IN, D'Cruz D, et al. . The British society for rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatol (Oxford) (2018) 57(1):e1&#x2013;e45. doi: 10.1093/rheumatology/kex286</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kex286</ArticleId><ArticleId IdType="pubmed">29029350</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakharova MY, Belyanina TA, Sokolov AV, Kiselev IS, Mamedov AE. The contribution of major histocompatibility complex class II genes to an association with autoimmune diseases. Acta Naturae (2019) 11(4):4&#x2013;12. doi: 10.32607/20758251-2019-11-4-4-12</Citation><ArticleIdList><ArticleId IdType="doi">10.32607/20758251-2019-11-4-4-12</ArticleId><ArticleId IdType="pmc">PMC6977962</ArticleId><ArticleId IdType="pubmed">31993230</ArticleId></ArticleIdList></Reference><Reference><Citation>Luque A, Serrano I, Ripoll E, Malta C, Goma M, Blom AM, et al. . Noncanonical immunomodulatory activity of complement regulator C4BP(beta-) limits the development of lupus nephritis. Kidney Int (2020) 97(3):551&#x2013;66. doi: 10.1016/j.kint.2019.10.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2019.10.016</ArticleId><ArticleId IdType="pubmed">31982108</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang D, Chen X, Kroemer G. Cuproptosis: a copper-triggered modality of mitochondrial cell death. Cell Res (2022) 32(5):417&#x2013;8. doi: 10.1038/s41422-022-00653-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-022-00653-7</ArticleId><ArticleId IdType="pmc">PMC9061796</ArticleId><ArticleId IdType="pubmed">35354936</ArticleId></ArticleIdList></Reference><Reference><Citation>Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol (2018) 18(2):134&#x2013;47. doi: 10.1038/nri.2017.105</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.105</ArticleId><ArticleId IdType="pubmed">28990587</ArticleId></ArticleIdList></Reference><Reference><Citation>Chasset F, Arnaud L. Targeting interferons and their pathways in systemic lupus erythematosus. Autoimmun Rev (2018) 17(1):44&#x2013;52. doi: 10.1016/j.autrev.2017.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2017.11.009</ArticleId><ArticleId IdType="pubmed">29108825</ArticleId></ArticleIdList></Reference><Reference><Citation>Moser KL, Kelly JA, Lessard CJ, Harley JB. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun (2009) 10(5):373&#x2013;9. doi: 10.1038/gene.2009.39</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gene.2009.39</ArticleId><ArticleId IdType="pmc">PMC3144759</ArticleId><ArticleId IdType="pubmed">19440199</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrillo-Vazquez DA, Jardon-Valadez E, Torres-Ruiz J, Juarez-Vega G, Maravillas-Montero JL, Meza-Sanchez DE, et al. . Conformational changes in myeloperoxidase induced by ubiquitin and NETs containing free ISG15 from systemic lupus erythematosus patients promote a pro-inflammatory cytokine response in CD4(+) T cells. J Transl Med (2020) 18(1):429. doi: 10.1186/s12967-020-02604-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02604-5</ArticleId><ArticleId IdType="pmc">PMC7659105</ArticleId><ArticleId IdType="pubmed">33176801</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleith RC, Mears HV, Leong XY, Sanford TJ, Emmott E, Graham SC, et al. . IFIT3 and IFIT2/3 promote IFIT1-mediated translation inhibition by enhancing binding to non-self RNA. Nucleic Acids Res (2018) 46(10):5269&#x2013;85. doi: 10.1093/nar/gky191</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky191</ArticleId><ArticleId IdType="pmc">PMC6007307</ArticleId><ArticleId IdType="pubmed">29554348</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JH, Dai M, Cui YG, Hou GJ, Deng J, Gao X, et al. . Association of abnormal elevations in IFIT3 with overactive cyclic GMP-AMP Synthase/Stimulator of interferon genes signaling in human systemic lupus erythematosus monocytes. Arthritis Rheumatol (2018) 70(12):2036&#x2013;45. doi: 10.1002/art.40576</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40576</ArticleId><ArticleId IdType="pubmed">29806091</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernales I, Fullaondo A, Marin-Vidalled MJ, Ucar E, Martinez-Taboada V, Lopez-Hoyos M, et al. . Innate immune response gene expression profiles characterize primary antiphospholipid syndrome. Genes Immun (2008) 9(1):38&#x2013;46. doi: 10.1038/sj.gene.6364443</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.gene.6364443</ArticleId><ArticleId IdType="pubmed">17960154</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Hanlon TP, Rider LG, Gan L, Fannin R, Paules RS, Umbach DM, et al. . Gene expression profiles from discordant monozygotic twins suggest that molecular pathways are shared among multiple systemic autoimmune diseases. Arthritis Res Ther (2011) 13(2):R69. doi: 10.1186/ar3330</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar3330</ArticleId><ArticleId IdType="pmc">PMC3132064</ArticleId><ArticleId IdType="pubmed">21521520</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y, Zheng Y, Li D, Hong Q, Zhang M, Li Q, et al. . Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analyses. EBioMedicine (2021) 70:103477. doi: 10.1016/j.ebiom.2021.103477</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103477</ArticleId><ArticleId IdType="pmc">PMC8318865</ArticleId><ArticleId IdType="pubmed">34284174</ArticleId></ArticleIdList></Reference><Reference><Citation>Bing PF, Xia W, Wang L, Zhang YH, Lei SF, Deng FY. Common marker genes identified from various sample types for systemic lupus erythematosus. PloS One (2016) 11(6):e0156234. doi: 10.1371/journal.pone.0156234</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0156234</ArticleId><ArticleId IdType="pmc">PMC4892593</ArticleId><ArticleId IdType="pubmed">27257790</ArticleId></ArticleIdList></Reference><Reference><Citation>Bignon A, Gaudin F, Hemon P, Tharinger H, Mayol K, Walzer T, et al. . CCR1 inhibition ameliorates the progression of lupus nephritis in NZB/W mice. J Immunol (2014) 192(3):886&#x2013;96. doi: 10.4049/jimmunol.1300123</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1300123</ArticleId><ArticleId IdType="pubmed">24367031</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai LJ, Lan JL, Lin CY, Hsiao SH, Tsai LM, Tsai JJ. The different expression patterns of interleukin-1 receptor antagonist in systemic lupus erythematosus. Tissue Antigens (2006) 68(6):493&#x2013;501. doi: 10.1111/j.1399-0039.2006.00704.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0039.2006.00704.x</ArticleId><ArticleId IdType="pubmed">17176440</ArticleId></ArticleIdList></Reference><Reference><Citation>Idborg H, Zandian A, Sandberg AS, Nilsson B, Elvin K, Truedsson L, et al. . Two subgroups in systemic lupus erythematosus with features of antiphospholipid or sjogren's syndrome differ in molecular signatures and treatment perspectives. Arthritis Res Ther (2019) 21:62. doi: 10.1186/s13075-019-1836-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-019-1836-8</ArticleId><ArticleId IdType="pmc">PMC6378708</ArticleId><ArticleId IdType="pubmed">30777133</ArticleId></ArticleIdList></Reference><Reference><Citation>Irudayam JI, Contreras D, Spurka L, Subramanian A, Allen J, Ren S, et al. . Characterization of type I interferon pathway during hepatic differentiation of human pluripotent stem cells and hepatitis c virus infection. Stem Cell Res (2015) 15(2):354&#x2013;64. doi: 10.1016/j.scr.2015.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2015.08.003</ArticleId><ArticleId IdType="pmc">PMC4600668</ArticleId><ArticleId IdType="pubmed">26313525</ArticleId></ArticleIdList></Reference><Reference><Citation>Minutti CM, Garcia-Fojeda B, Saenz A, de Las Casas-Engel M, Guillamat-Prats R, de Lorenzo A, et al. . Surfactant protein a prevents IFN-gamma/IFN-gamma receptor interaction and attenuates classical activation of human alveolar macrophages. J Immunol (2016) 197(2):590&#x2013;8. doi: 10.4049/jimmunol.1501032</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1501032</ArticleId><ArticleId IdType="pubmed">27271568</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong SM, Liu C, Yin Z, Wu L, Qu B, Shen N. MicroRNAs in systemic lupus erythematosus: a perspective on the path from biological discoveries to clinical practice. Curr Rheumatol Rep (2020) 22(6):17. doi: 10.1007/s11926-020-00895-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-020-00895-7</ArticleId><ArticleId IdType="pubmed">32405712</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Lei H, Li X. LncRNA SNHG14 contributes to proinflammatory cytokine production in rheumatoid arthritis via the regulation of the miR-17-5p/MINK1-JNK pathway. Environ Toxicol (2021) 36(12):2484&#x2013;92. doi: 10.1002/tox.23361</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/tox.23361</ArticleId><ArticleId IdType="pubmed">34529319</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai D, Hong S, Yang J, San P. The effects of microRNA-515-5p on the toll-like receptor 4 (TLR4)/JNK signaling pathway and WNT1-Inducible-Signaling pathway protein 1 (WISP-1) expression in rheumatoid arthritis fibroblast-like synovial (RAFLS) cells following treatment with receptor activator of nuclear factor-kappa-B ligand (RANKL). Med Sci Monit (2020) 26:e920611. doi: 10.12659/MSM.920611</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.920611</ArticleId><ArticleId IdType="pmc">PMC7216564</ArticleId><ArticleId IdType="pubmed">32361708</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou SL, Zhang J, Luan PF, Ma ZB, Dang J, Zhu H, et al. . miR-183-5p is a potential molecular marker of systemic lupus erythematosus (vol 2021, 5547635, 2021). J Immunol Res (2021) 2021:5547635. doi:&#xa0;10.1155/2021/5547635</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/5547635</ArticleId><ArticleId IdType="pmc">PMC8124875</ArticleId><ArticleId IdType="pubmed">34036107</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan C, Ping CY, Shang XY, Tian JT, Zhao SH, Li L, et al. . MicroRNA 182 inhibits CD4(+)CD25(+)Foxp3(+) treg differentiation in experimental autoimmune encephalomyelitis. Clin Immunol (2016) 173:109&#x2013;16. doi: 10.1016/j.clim.2016.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2016.09.008</ArticleId><ArticleId IdType="pubmed">27664932</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, He QY, Guo ZZ, Xiong F, Li Y, Pan Y, et al. . MicroRNA-425 facilitates pathogenic Th17 cell differentiation by targeting forkhead box O1 (Foxo1) and is associated with inflammatory bowel disease. Biochem Bioph Res Co (2018) 496(2):352&#x2013;8. doi: 10.1016/j.bbrc.2018.01.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2018.01.055</ArticleId><ArticleId IdType="pubmed">29331376</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu Y, Zhao C, Zhang B, Wang X, Wang Y, An J, et al. . Restoring T-helper 17 cell/regulatory T-cell balance and decreasing disease activity by rapamycin and all-trans retinoic acid in patients with systemic lupus erythematosus. Lupus (2019) 28(12):1397&#x2013;406. doi: 10.1177/0961203319877239</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203319877239</ArticleId><ArticleId IdType="pubmed">31551029</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassani B, Villablanca EJ, De Calisto J, Wang S, Mora JR. Vitamin a and immune regulation: role of retinoic acid in gut-associated dendritic cell education, immune protection and tolerance. Mol Aspects Med (2012) 33(1):63&#x2013;76. doi: 10.1016/j.mam.2011.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2011.11.001</ArticleId><ArticleId IdType="pmc">PMC3246074</ArticleId><ArticleId IdType="pubmed">22120429</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J, Yu J, Tao X, Cai L, Wang J, Zheng SG. The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients. Clin Rheumatol (2010) 29:1251&#x2013;8. doi: 10.1007/s10067-010-1510-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-010-1510-7</ArticleId><ArticleId IdType="pubmed">20563617</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Wang W, Xu J, Wu S, Le Q. All-trans retinoid acid promotes allogeneic corneal graft survival in mice by regulating treg-Th17 balance in the presence of TGF-&#x3b2;. BMC Immunol (2015) 16(1):1&#x2013;13. doi: 10.1186/s12865-015-0082-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12865-015-0082-3</ArticleId><ArticleId IdType="pmc">PMC4395899</ArticleId><ArticleId IdType="pubmed">25887926</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanov II, Zhou L, Littman DR. Transcriptional regulation of Th17 cell differentiation. In: Seminars in immunology. Elsevier; (2007). p. 409&#x2013;17. doi:&#xa0;10.1016/j.smim.2007.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2007.10.011</ArticleId><ArticleId IdType="pmc">PMC2696342</ArticleId><ArticleId IdType="pubmed">18053739</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei S, Yoshida N, Finn G, Kozono S, Nechama M, Kyttaris VC, et al. . Rheumatology, Pin1-targeted therapy for systemic lupus erythematosus. Arthritis Rheumatol (2016) 68(10):2503&#x2013;13. doi:&#xa0;10.1002/art.39741</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39741</ArticleId><ArticleId IdType="pmc">PMC5493308</ArticleId><ArticleId IdType="pubmed">27159270</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>